[PDF] Top 20 La investigación en Historia del Arte en el Centro de Estudios Históricos de la JAE
Has 10000 "La investigación en Historia del Arte en el Centro de Estudios Históricos de la JAE" found on our website. Below are the top 20 most common "La investigación en Historia del Arte en el Centro de Estudios Históricos de la JAE".
Incorporation of tissue-based genomic biomarkers into localized prostate cancer clinics
... Localized prostate cancer (PCa) is a clinically heterogeneous disease, which presents with variability in patient outcomes within the same risk stratification (low, intermediate or high) and even ... See full document
10
Random forest-based modelling to detect biomarkers for prostate cancer progression
... mainly localized in CpG islands, shores and shelves, while DMS with loss in methylation were mostly located in inter- genic (open sea) regions ...specific genomic regions, we used the EpiAnnotator tool and ... See full document
5
Methylation pattern analysis in prostate cancer tissue: identification of biomarkers using an MS MLPA approach
... curve based on the generation of different proportions (5, 10, 20, 40, 80, 100 %) of DNA derived from a prostate can- cer cell line (LNCaP) with known methylation of GSTP1, RASSF1, SCGB3A1, CASP8, RARB, ... See full document
6
Patient educational technologies and their use by patients diagnosed with localized prostate cancer
... PETs offer an opportunity to better understand how pa- tients’ patterns of information needs change after diag- nosis with prostate cancer. The PET library used in this study provides far more insight into ... See full document
8
Genomic Predictors of Outcome in Prostate Cancer
... significant impact on treatment decisions, follow-up data were not reported to determine the long-term impact of these changes in management. Furthermore, the test remains very expensive (approximately $3400), and ... See full document
154
Emerging biomarkers in the diagnosis of prostate cancer
... to support the prognostic value of CTC in localized PCa. The clinical utility of CTCs has been evaluated primarily for their application in patients with metastatic PCa. In advanced stages, androgen deprivation ... See full document
10
PROSTATE CANCER GRADING – A REVIEW ON HISTOPATHOLOGY IMAGES Maneesh M, Dr Smitha P, Dr Sujathan K Abstract PDF IJIRMET160401002
... TMA tissue core from the background using intensity threshold and convex ...(broken tissue areas) in the ...methods based on fractal dimension to analyze variations of intensity and texture ... See full document
17
Postcolonial Trauma Narratives: Traumatic Historiography and Identity in Amitav Ghosh's The Calcutta Chromosome
... 1, prostate cancer is the most common cause of tumor-related death in men in the western ...National Cancer Institute’s estimation, about 240,890 new cases occur in 2011 while 33,720 people are ...of ... See full document
19
Graphene-based biosensors for the detection of prostate cancer protein biomarkers: a review
... protein biomarkers. In this review, the commonly used PC protein biomarkers for biosensor, the unique properties of graphene and the roles of gra- phene-based materials for biosensing were ...protein ... See full document
21
Erectile function after permanent 125I prostate brachytherapy for localized prostate cancer
... Patients often choose brachytherapy because it is re- puted to be less damaging to erectile function. In this study we observed that 36 months after implantation, 73% of men with a IIEF score more than 12 before PB had a ... See full document
30
<p>Biomarkers That Differentiate Benign Prostatic Hyperplasia from Prostate Cancer: A Literature Review</p>
... protein biomarkers, combined with clinical information, such as age and DRE results, the model achieved an AUC of ...risk- based model (S3M) incorporates several plasma protein biomarkers (PSA, free ... See full document
60
Nomograms as Predictive Tools for Prostate Cancer Patients Who Had Radical Prostatectomy
... cludes Cancer of the Prostate Strategic Urologic Re- search Endeavor (CaPSURE) data was produced to pre- dict continence, erection status with physical and mental outcomes in the first year after RP ... See full document
119
Fine-mapping of the HNF1B multicancer locus identifies candidate variants that mediate endometrial cancer risk
... (COGS), Cancer Research UK (C1287/A10118, C1287/A 10710, C12292/A11174, C1281/A12014, C5047/A8384, C5047/A15007 and C5047/A10692), the National In- stitutes of Health (CA128978) and Post-Cancer GWAS ... See full document
10
CART cell therapy for prostate cancer: status and promise
... against prostate cancer, and the second-generation CAR-T cells have a better killing effect than the first generation and provide a novel approach for clinical immune-targeted therapy for ... See full document
15
Explicit treatment advice in urology: Trick or Treat?
... choice. Based on these results, measuring preferences is recommended to increase their thinking about the benefits and risks and more importantly their understanding what the most important aspects for them ... See full document
167
Role of magnetic resenonce spectroscopy as a noninvasive diagnostic investigation in carcinoma prosatate.
... All hypoechoic lesions within the PZ should by noted and included in the biopsy material. The lack of a distinct hypoechoic focus does not preclude proceeding with biopsy because 39% of all cancers are isoechoic and up ... See full document
Serum and tissue miRNAs: potential biomarkers for the diagnosis of cervical cancer
... MiRNAs belong to a novel category of non-coding RNA molecules that interconnect to target mRNA to degrade or translate repression. Their detection opened a new intuition to the perception of intricate gene regu- latory ... See full document
23
Treatment trends and Medicare reimbursements for localized prostate cancer in elderly patients
... The current study relied on the SEER-Medicare insurance program-linked database. 16 Between 2000 and 2008, we identified patients aged ≥80 years, with clinically localized (stage T1-T2) histologically confirmed ... See full document
18
Factors underlying treatment decision making for localized prostate cancer in the U S and Canada: A scoping review using principal component analysis
... Applying PCA to the 32 identified topics resulted in five overarching factors (see Table 3): treatment type, socioeconomic/demographic characteristics, personal reasons for treatment choice, psychology of treatment ... See full document
6
Is there an optimal management for localized prostate cancer?
... with prostate-specific antigen (PSA) has led to a signifi- cant increase in the detection of early stage, clinically localized prostate cancer ...for localized CaP are discussed in this ... See full document
12
Related subjects